
Please try another search
Medeon Biodesign, Inc. researches, develops, manufactures, and sells medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose to prevent port site herniation caused by improper closure. It is involved in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices. The company was incorporated in 2012 and is based in Taipei, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Yue-Teh Jang | - | 2012 | Chairman of the Board & GM |
Chih-Hsiung Wu | - | 2016 | Representative Director |
Rongjin Lin | - | - | Board Director |
Jung-Chin Lin | 69 | 2014 | Representative Director |
Chih-Hang Yang | - | 2015 | Independent Director |
Chia-Ying Ma | 65 | 2015 | Independent Director |
Jien Wei Yeh | - | 2023 | Independent Board Director |
Shyang Yang Feng | - | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review